Harlan S Robins
Chief Scientific Officer · 8 filings · Latest: Jul 21, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | Harlan Robins | — | Mar 2, 2026 | Proposed Sale | $16.12 | 10,000 | $161.2K | — | |
ADPT | Harlan S Robins | Chief Scientific Officer | Feb 3, 2026 | Sale | $19.00 | 8,120 | $154.3K | 1,179,524 | |
ADPT | Harlan S Robins | Chief Scientific Officer | Feb 2, 2026 | Sale | $18.60 | 34,668 | $644.8K | 1,187,644 | |
ADPT | Harlan Robins | — | Feb 3, 2026 | Proposed Sale | $18.50 | 8,120 | $150.2K | — | |
ADPT | Harlan Robins | — | Feb 2, 2026 | Proposed Sale | $18.39 | 34,668 | $637.5K | — | |
ADPT | Harlan Robins | — | Jan 6, 2026 | Proposed Sale | $16.11 | 10,000 | $161.1K | — | |
ADPT | Harlan Robins | — | Dec 4, 2025 | Proposed Sale | $17.46 | 10,000 | $174.6K | — | |
ADPT | Harlan Robins | — | Dec 3, 2025 | Proposed Sale | $17.13 | 27,212 | $466.1K | — | |
ADPT | Harlan Robins | — | Nov 10, 2025 | Proposed Sale | $14.71 | 10,000 | $147.1K | — | |
ADPT | Harlan Robins | — | May 1, 2025 | Proposed Sale | $7.36 | 68,412 | $503.5K | — |
← Previous
Page 2 of 2